Enventys Partners and Stratasys Slash Development and Production Costs In Half While Maintaining Quality in New Head Lice Treatment Device
Share Article
3D printing with Stratasys’ Origin One enables Enventys Partners to design, develop, and deliver end-use head lice treatment devices without the lead time, costs, and design constraints of injection molding or CNC machining.
The Origin One 3D printer allowed us to make several initial options for our client to choose from and then make tiny tweaks almost in real-time without delaying the project or incurring huge expenses. CHARLOTTE, N.C. (PRWEB) February 25, 2021 Enventys Partners is leveraging Origin s Programmable PhotoPolymerization (P3) technology from Stratasys to design and deliver a new head lice treatment device at a fraction of the cost of traditional manufacturing. The partnership marks a new frontier in product development and manufacturing in whic
Mergers and acquisitions are good for the 3D printing industry
Industry acquisition 3D printer pioneer Stratasys bought Origin benefits both companies
Getty Images
Mergers and acquisitions were cruising along at the start of 2020 until the COVID-19 outbreak. Then, like many aspects of life, M&A activity slowed to a jerky roll.
Between Q1 and Q2 2020 “the number of globally announced deals dropped from 11,304 to 8,920, with deal value decreasing from just over $555 billion to about $363 billion,” according to a report published in September by Deloitte/
The Wall Street Journal. The financial consulting firm also reported that some companies are resuming, or even accelerating, their M&A activities in preparation of a post-COVID world.
Stratasys paying $100 million for Origin rubbernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rubbernews.com Daily Mail and Mail on Sunday newspapers.
Stratasys to Acquire Origin, for $100M
Rehovot, Israel-based
Stratasys Ltd. (NASDAQ: SSYS) is to acquire 3D San Francisco, CA-based printing startup Origin Inc., for total consideration of up to $100m, including cash and stock.
Subject to various approvals and other closing conditions, the acquisition is expected to close in January 2021. Under the terms of the deal, the total consideration for the transaction is comprised of $60m paid on closing ($6m of which is subject to the founders’ retention over 3 years) and $40m that is subject to performance-based earnouts over 3 years. The acquisition will be paid using a combination of stock of approximately $45m and cash of approximately $55m at closing and throughout the earnout period. Approximately $32m of the cash expenditure will be at closing.